Amedeo Smart

Free Medical Literature Service

 

Amedeo

Prostate Cancer
  Free Subscription

Articles published in
Radiology
    December 2025
  1. WOO S, Masci B, Rowe SP, Caruso D, et al
    Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET.
    Radiology. 2025;317:e250701.
    >> Share

  2. ULANER GA, Bassett JC, Reddy R, Thomsen B, et al
    (61)Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of (61)Cu-labeled PET Radiotracers.
    Radiology. 2025;317:e251151.
    >> Share

    July 2025
  3. SATTIN C, Pizzi C, Summers P, Gaeta A, et al
    Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer Diagnosis.
    Radiology. 2025;316:e241710.
    >> Share

    May 2025
  4. METSER U, Zukotynski K, Mak V, Langer D, et al
    Erratum for: Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2025;315:e259010.
    >> Share

    April 2025
  5. WESTPHALEN AC
    Building the Foundation for AI in Prostate Cancer Imaging.
    Radiology. 2025;315:e243352.
    >> Share

  6. TURKBEY B, Huisman H, Fedorov A, Macura KJ, et al
    Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
    Radiology. 2025;315:e240140.
    >> Share

    March 2025
  7. TAKAHASHI T
    Prostate Cancer Screening: Empirical Clinical Practice for 70 Years.
    Radiology. 2025;314:e242184.
    >> Share

  8. LEE YJ, Moon HW, Choi MH, Eun Jung S, et al
    MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.
    Radiology. 2025;314:e232788.
    >> Share

  9. HARMATH C
    AI in Prostate Cancer Diagnosis with MRI: A Friend Not a Foe.
    Radiology. 2025;314:e250525.
    >> Share

    February 2025
  10. STEINHELFER L, Jungmann F, Nickel M, Kaissis G, et al
    Automated CT Measurement of Total Kidney Volume for Predicting Renal Function Decline after (177)Lu Prostate-specific Membrane Antigen-I&T Radioligand Therapy.
    Radiology. 2025;314:e240427.
    >> Share

    January 2025
  11. HUANG H, Mo J, Ding Z, Peng X, et al
    Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer.
    Radiology. 2025;314:e240238.
    >> Share

    December 2024
  12. CORNUD F, de Bie K, van Riel L, Lefevre A, et al
    MRI-directed Micro-US-guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study.
    Radiology. 2024;313:e233371.
    >> Share

    October 2024
  13. YANG DD, Lee LK, Tsui JMG, Leeman JE, et al
    AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer.
    Radiology. 2024;313:e240041.
    >> Share

    September 2024
  14. TAKAHASHI T
    Rationale for MRI-guided Focused Ultrasound Focal Therapy for Prostate Cancer.
    Radiology. 2024;312:e240738.
    >> Share

    August 2024
  15. JOHNSON PM, Chandarana H
    AI-powered Diagnostics: Transforming Prostate Cancer Diagnosis with MRI.
    Radiology. 2024;312:e241009.
    >> Share

  16. CAI JC, Nakai H, Kuanar S, Froemming AT, et al
    Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI.
    Radiology. 2024;312:e232635.
    >> Share

  17. CIVELEK AC
    Prostate Cancer: Improved Patient Care in the Age of Advancing Theranostics.
    Radiology. 2024;312:e241564.
    >> Share

  18. OERTHER B, Nedelcu A, Engel H, Schmucker C, et al
    Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis.
    Radiology. 2024;312:e233337.
    >> Share

  19. KOHLBRENNER R, Wu X, Nguyen HG, Cooperberg MR, et al
    Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
    Radiology. 2024;312:e232544.
    >> Share

  20. TAMMISETTI VS, Jacobs MA
    Evidence-based Diagnostic Performance Benchmarks in Prostate MRI: An Unmet Clinical Need.
    Radiology. 2024;312:e241792.
    >> Share

  21. KUO PH, Morris MJ, Hesterman J, Kendi AT, et al
    Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial).
    Radiology. 2024;312:e233460.
    >> Share

    July 2024
  22. GHAI S, Klotz L, Pond GR, Kebabdjian M, et al
    Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e231948.
    >> Share

  23. SCIALPI M, Martorana E
    Apparent Diffusion Coefficient and Biopsy in Detecting Cribriform and Intraductal Carcinoma Prostate Cancer.
    Radiology. 2024;312:e241043.
    >> Share

    June 2024
  24. SCHIEDA N, Nisha Y, Hadziomerovic AR, Prabhakar S, et al
    Comparison of Positive Predictive Values of Biparametric MRI and Multiparametric MRI-directed Transrectal US-guided Targeted Prostate Biopsy.
    Radiology. 2024;311:e231383.
    >> Share

  25. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Erratum for: Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e249017.
    >> Share

    May 2024
  26. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
    Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Radiology. 2024;311:e230750.
    >> Share

  27. PRIVE BM, Israel B, Janssen MJR, van der Leest MMG, et al
    Multiparametric MRI and (18)F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.
    Radiology. 2024;311:e231879.
    >> Share

    April 2024
  28. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
    Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
    Radiology. 2024;311:e231703.
    >> Share

    March 2024
  29. WOODRUM DA
    Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
    Radiology. 2024;310:e240258.
    >> Share

  30. GHAI S, Finelli A, Corr K, Lajkosz K, et al
    MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
    Radiology. 2024;310:e231473.
    >> Share

    December 2023
  31. MURAD V, Glicksman RM, Berlin A, Santiago A, et al
    Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
    Radiology. 2023;309:e231407.
    >> Share

  32. ALABOUSI M, Ghai S, Haider MA
    MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
    Radiology. 2023;309:e230431.
    >> Share

  33. CIVELEK AC
    PSMA PET Parameters for Predicting Outcomes in Patients with Prostate Cancer.
    Radiology. 2023;309:e233023.
    >> Share

    November 2023
  34. TAKAHASHI T
    Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
    Radiology. 2023;309:e231177.
    >> Share

  35. AGUIRRE DA, Cardona Ortegon JD
    Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
    Radiology. 2023;309:e232819.
    >> Share

  36. LUZZAGO S, Colombo A, Mistretta FA, Alessi S, et al
    Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Radiology. 2023;309:e223349.
    >> Share

    September 2023
  37. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016